Sixth Street-backed Caris Life Sciences targets $5.3 billion valuation in US IPO
(Reuters) -Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.35 billion in its initial public offering in the United States.
Irving, Texas-based Caris plans to raise up to $424 million by offering 23.5 million shares priced between $16 and $18 apiece.
The IPO market is heating up as high-profile companies move ahead with their stock market listings in a calmer period after tariff-related volatility stifled deal activity earlier this year.
In 2021, Caris raised $830 million at a $7.83 billion valuation in a funding round led by investment firm Sixth Street.
Caris will trade on the Nasdaq under the symbol "CAI."
BofA Securities, J.P. Morgan, Goldman Sachs, and Citigroup are the lead underwriters for the offering.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Loving Giving Local: Rhoxon Productions
Movie enthusiasts will benefit from this week's Loving Giving Local donation. A local movie production company that sponsors a film festival is this week's recipient. Rhoxon Productions got a financial gift from Auto Express Resale Center. Rhoxon is an Erie-based non-profit independent film company that creates organic stories that promote a positive change. Besides creating art, Rhoxon strives to create jobs and educational opportunities in the film industry. 'Our last few projects have been about healing and about coping, and our next two are about revamping the social justice system,' said Katie Nixon, RhoxonProductions co-founder. 'That's sort of our creative endeavors, and we also create educational opportunities for people to learn how to do this professionally.' Nixon says Rhoxon has a vision of creating 50 new jobs in the film industry here. And she insists you no longer have to be on the East or West Coast to have a film career. 'No, the landscape has changed so much. Even Netflix has created their new studio out in Jersey. It's not just that you have be in New York or LA,' she explained. 'Erie is kinda a really interesting place. You have beach, you have woods, you have city, you have country all within 15 minutes of each other.' That landscape diversity, Nixon said, makes Northwest Pennsylvania the perfect place for shooting movies. This week's Loving Giving Local donation will help support an upcoming film festival. Nixon said, 'We started the only multi-genre film festival here in Erie. It's the Lake Effect Film Festival, which will be in September. So that money will go to help make that event possible.' After making his check presentation, Joe Askins of Auto Express Resale Center said, 'We're pretty fortunate to have Rhoxon in our community and they're already doing great things. So for us to be able to deliver loving giving local and to learn the donation we bring is going toward their film festival, that's what Loving Giving Local is all about,' Askins said. You can learn more about the film festival and Rhoxon's work here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
35 minutes ago
- Yahoo
Rockford hydroelectric project aims to power five homes with clean energy
ROCKFORD, Ill. (WTVO) — A Rockford-based company wants to harness the Rock River to produce energy to power homes. Latitude Power of Rockford partnered with design firm Studio GWA to create a pilot project that would use hydroelectric generators to create enough clean energy to supply electricity to five homes. 'Essentially, it takes wasted energy that's either flowing over a dam, or anywhere water is falling,' said Jared Cacciatore, Latitude Power co-founder. Rockford's Fordam dam will soon become the pilot program's test site, where a micro hydroelectric generator will be installed. 'We can take that water, that which is potential energy, and turn it into mechanical energy through a turbine and a generator, and then turn that into, you know, electrical energy,' Cacciatore said. Latitude Power received state funding through Illinois' Climate and Equitable Jobs Act (CEJA) to help develop the project. 'The company here won a nearly $1 million grant to produce hydroelectric power and uses the Rock River to generate electricity, which is a great concept. The Rock River has been a huge asset for this area, so it seems to be the next step in using this asset to generate clean power and provide electricity throughout the area,' said Sen. Steve Stadelman (D-Rockford). Latitude has already done smaller-scale testing, but moving to the Rock River means new challenges. 'It performs pretty, pretty well at the wastewater plant. But this is a new environment. It's a new, you know, there are new challenges. Will it will it be safe from vandalism? Will we be safe from other things we haven't thought of?' Cacciatore said. The company hopes the pilot project will generate enough electricity to power five homes. If successful, it plans to scale up from there. 'We want to help to help Rockford become a beacon of clean energy, a beacon of collaborative community involvement and advocacy for each other and for for the community and for the the greater good for the planet,' Cacciatore said. Once the grant funding is in place, Latitude hopes to have the project done within 18-20 months. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
38 minutes ago
- Yahoo
Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM)
Insmed Incorporated (NASDAQ:INSM) is among the 13 Biotech Stocks with Huge Upside Potential. Kelly Shi of Jefferies has given Insmed Incorporated (NASDAQ:INSM) a buy recommendation, stating that she is confident in the TPIP treatment's impending Phase 2 data for pulmonary arterial hypertension. A biopharmaceutical research team taking notes in front of a laboratory's microscope. Shi anticipates a substantial decrease in pulmonary vascular resistance, the main outcome of the trial, of 20%, which is regarded as a definite success. If the results are encouraging, TPIP may replace Tyvaso, the current standard treatment. On June 4, Wells Fargo reaffirmed its Buy recommendation, with a price objective of $107. Shi points out that TPIP's once-daily dosage is a significant benefit over Tyvaso's four-times-daily schedule, which could increase adherence and make it more appealing to patients as well as physicians. The efficacy potential of TPIP is supported by interim study results that show additional advantages in six-minute walk distance (6MWD). Shi expects significant market penetration in light of these considerations, which could lead to an increase in Insmed Incorporated (NASDAQ:INSM)'s valuation. Both analysts highlight that if future trial results live up to predictions, TPIP has the potential to completely change the way that PAHs are treated. Insmed Incorporated (NASDAQ:INSM) is a biopharmaceutical firm that improves the lives of individuals suffering from serious and rare diseases. While we acknowledge the potential of INSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
